Significance of Hepatitis B Viremia Levels Determined by a Quantitative Polymerase Chain Reaction Assay in Patients With Hepatitis B e Antigen-Negative Chronic Hepatitis B Virus Infection

American Journal of Gastroenterology

Volumn 98, Issue 10, 2003, Pages 2261-2267

  Manesis, Emanuel K ^b   Papatheodoridis, George V ^b   Sevastianos, Vasilios ^b   Cholongitas, Evangelos ^b   Papaioannou, Christos ^b   Hadziyannis, Stephanos J ^a  

^a HENRY DUNANT HOSPITAL   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE GENETICS; VIREMIA; VIRUS CARRIER;

EID: 0142214798     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(03)00748-2     Document Type: Article

References (32)

1. Hadziyannis SJ. Hepatitis B e antigen negative chronic hepatitis B: From clinical recognition to pathogenesis and treatment. Vir Hep Rev 1995;1:7-36.
2. Di Marco V, Lo Iakono O, Camma C, et al. The long-term course of chronic hepatitis B. Hepatology 1999;30:257-64.
3. Villeneuve J-P, Descrochers M, Infante-Rivard C, et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994;106:1000-5.
4. Papatheodoridis GV, Hadziyannis SJ. Diagnosis and management of pre-core mutant chronic hepatitis B. J Viral Hep 2001;8:311-21.
5. Brunetto MR, Giarin M, Oliveri F, et al. Wild type and e antigen-minus hepatitis B virus in course of chronic hepatitis. Proc Natl Acad Sci U S A 1991;88:4186-90.
6. Hadziyannis S, Bramou A, Alexopoulou A, et al. Immunopathogenesis and natural course of anti-HBe-positive chronic hepatitis with replicating B virus. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins, 1991:673-6.
7. Hadziyannis SJ, Hadziyannis AS, Dourakis S, et al. Clinical significance of quantitative anti-HBc IgM assay in acute and chronic HBV infection. Hepatogastroenterology 1993;40:588-92.
8. Brunetto MR, Cerenzia MR, Oliveri F, et al. Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol 1993;19:431-6.
9. Hayashi PH, Beames MP, Kuhns MC, et al. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B. Am J Gastroenterol 1996;91:2323-8.
10. Colloredo G, Bellati G, Leandro G, et al. Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new "gray zone" for evaluation of "borderline" values. J Hepatol 1996;25:644-8.
11. Pawlotsky J-M. Molecular diagnosis of viral hepatitis. Gastroenterology 2002;122:1554-68.
12. Kaneko M, Miller RH, Di Bisceglie AM, et al. Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis. Gastroenterology 1990;99:799-804.
13. Jardi R, Buti M, Rodriguez-Frias F, et al. The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J Hepatol 1996;24:680-5.
14. Gerken G, Gomez J, Lambertico P, et al. Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay. J Virol Methods 1998;74:155-65.
15. Hwang SJ, Lee SD, Lu RH, et al. Comparison of three different hybridisation assays in the quantitative measurement of serum hepatitis B virus DNA. J Virol Methods 1996;62:123-9.
16. Kessler HH, Pierer K, Dragon E, et al. Evaluation of a new assay for HBV DNA quantitation in patients with chronic hepatitis B. Clin Diagn Virol 1998;9:37-43.
17. Jurinke C, Zollner B, Feucht HH, et al. Application of nested PCR and mass spectrometry for DNA-based virus detection: HBV-DNA detected in the majority of isolated anti-HBc positive sera. Genet Anal 1998;14:97-102.
18. Rasmussen R. Quantification on the LightCycler. In: Meyer S, Wittwer C, Nakagawara K, eds. Rapid cycle real time PCR-methods and applications. New York: Springer, 2001:21-34.
19. Pawlotsky J-M, Bastie A, Lonjon I, et al. What techniques should be used for routine detection and quantification of HBV DNA in clinical samples? J Virol Methods 1997;65:245-53.
20. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 2001;120:1828-53.
21. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2001;34:1225-41.
22. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
23. Daly LE, Bourke GJ, McGilvray J. Interpretation and uses of medical statistics. London: Blackwell Science, 1991.
24. Martinot-Peignoux M, Boyer N, Colombat M, et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002;36:543-8.
25. Noborg U, Gusdal A, Horal P, et al. Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection. Scan J Infect Dis 2000;32:249-52.
26. Hoofnagle JH, Di Bisceglie AM. Serological diagnosis of acute and chronic viral hepatitis. Semin Liver Dis 1991;11:73-83.
27. Tassopoulos NC, Sjogren MH, Ticehurst JR, et al. Significance of IgM antibody to hepatitis core antigen in a Greek population with chronic hepatitis B virus infection. Liver 1986;6:275-80.
28. Mels GC, Bellati G, Leandro G, et al. Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver 1994;14:175-81.
29. ter Borg F, ten Kate FJW, Cuypers HTM, et al. Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen. Lancet 1998;351:1914-8.
30. Milich DR. Immune response to hepatitis B virus proteins: Relevance of the murine models. Semin Liver Dis 1991;11:93-112.
31. Zavaglia C, Mondazzi L, Maggi G, et al. Are alanine amino-transferase, hepatitis B virus DNA of IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B? Liver 1997;17:83-7.
32. Lindh M, Horal P, Dhillon AP, et al. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity of chronic hepatitis B. J Viral Hep 2000;7:258-67.